To recover your password please fill in your email address
Please fill in below form to create an account with us
Short Course Oncology Therapy: a study of adjuvant chemotherapy in colorectal cancer by the CACTUS and OCTO collaborative groups.
Trial Summary: |
This study is investigating the efficacy of 3 months of adjuvant chemotherapy versus 6 months in terms of 3-year disease-free survival, overall survival, toxicity, cost-effectiveness and quality of life. |
Supported By: |
CACTUS; Cancer Australia; NHMRC CTC; AGITG |
Eligibility: |
Patients with fully resected stage III colorectal cancer |
Registration ID: |
ACTRN12609000662268 |
Participation: |
International |
Australian Lead Group: |
AGITG |
Status: |
closed |
Activation Date: |
18/03/2010 |
Chairs: |
Tim Iveson (international), Andrew Haydon (Australia) |
Contact: |